Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CCL vs MRNA✓SelectedUSD · MRNACCL vs MRNA performance historyLatest closeAs of+2.88%11/18
Stock and ETF performance explorer

CCL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-45.1%
MRNA return
+794.5%
Excess return
-839.6%
Maximum drawdown
-88.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+2.9%-4.8%+7.7%+3.1%
7D-5.6%-20.9%+15.3%-4.6%
30D+10.1%-13.3%+23.4%+10.7%
3M+6.8%+212.6%-205.8%-1.6%
6M+17.5%+309.0%-291.5%+5.6%
YTD-3.1%+567.3%-570.4%-16.4%
1Y+14.9%+689.7%-674.8%-2.0%
3Y+100.0%+157.4%-57.4%+78.4%
5Y+41.2%-21.7%+62.9%+24.5%
All-45.1%+794.5%-839.6%-43.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling